Canadian Addiction Treatment Centres

Canadian Addiction Treatment Centres is a Canadian addiction care provider operating a national network of outpatient clinics, pharmacies, inpatient treatment centres, and virtual programs focused on substance use disorder treatment. The organization is best known for rapid-access, evidence-based care for opioid use disorder, including medication-assisted treatment with methadone and buprenorphine/naloxone, alongside counselling, case management, harm reduction, and some primary care services. CATC also offers residential addiction treatment, pharmacy support, and testing/treatment services for related infectious diseases such as hepatitis C and HIV. Founded in 1995, the company was acquired by BayMark Health Services in March 2018 but continues to operate under the CATC brand in Canada. It is a healthcare delivery organization rather than a drug development biotech or pharma company.